Advanced Search

column
Update on Diagnosis and Treatment of Gastrointestinal Stromal Tumors
LIN Chen, ZHANG Zaizhong, WANG Lie
2022, 49(1): 1-4. DOI: 10.3971/j.issn.1000-8578.2022.21.1205
Abstract FullText HTML PDF
MiRNA-129-5p Targeting HMGB1 Inhibits Proliferation and Migration of Osteosarcoma Cells
ZHANG Huaibin, YANG Guoqing, LIANG Wenqiang, XIE Ben, WANG Yongping
2022, 49(1): 5-11. DOI: 10.3971/j.issn.1000-8578.2022.21.0707
Abstract FullText HTML PDF
MiR-218-5p Promotes Rotenone-induced Apoptosis of Gastric Cancer Cells by Inhibiting TDP1 Expression
WANG Yuanyuan, LYU Xiaohong
2022, 49(1): 12-17. DOI: 10.3971/j.issn.1000-8578.2022.21.0840
Abstract FullText HTML PDF
Expression and Prognostic Value of Inward Rectifier Potassium Channel Subfamily J Member 11 mRNA in Gliomas
WANG Fang, ZHOU Kaijia, ZHAO Zheng, LIANG Hui, LIU Yanwei
2022, 49(1): 18-23. DOI: 10.3971/j.issn.1000-8578.2022.21.0574
Abstract FullText HTML PDF
Influence of SLC16A Family on Clinical Features and Biological Behaviours of Lung Adenocarcinoma and Squamous Cell Carcinoma
YUE Jing, KANG Jing, LI Guoyin
2022, 49(1): 24-31. DOI: 10.3971/j.issn.1000-8578.2022.21.0700
Abstract FullText HTML PDF
Research Progress of Exercise Intervention on Breast Cancer: A Visualization Analysis
HONG Chen, PENG Xinyu, GUO Yin, WANG Jingsong
2022, 49(1): 32-39. DOI: 10.3971/j.issn.1000-8578.2022.21.0911
Abstract FullText HTML PDF
Expression and Significance of PD-1, PD-L1 and PD-L2 in T Cell Subsets and Myeloma Cells in Newly Diagnosed Multiple Myeloma Patients
MA Yinjuan, YANG Ke, YANG Xiaying, BAI Jiaofeng, BAI Hai, WU Tao, FU Lihua, JIANG Junfeng, PAN Yaozhu
2022, 49(1): 40-45. DOI: 10.3971/j.issn.1000-8578.2022.21.0352
Abstract FullText HTML PDF
Real-world Research of Trastuzumab and Pertuzumab Combined with Chemotherapy in Neoadjuvant Treatment of HER2-positive Breast Cancer
MA Xiangmin, ZHANG Xiangmei, ZHOU Xinping, REN Xiaofei, ZHANG Weifang, LIU Yunjiang
2022, 49(1): 46-52. DOI: 10.3971/j.issn.1000-8578.2022.21.0802
Abstract FullText HTML PDF
Curative Effect of Lenvatinib Combined with Locoregional Therapy on PD-L1-positive Hepatocellular Carcinoma Patients with Type Ⅰ-Ⅲ Portal Vein Tumor Thrombus According to Cheng's Classification
CHEN Long, LIU Yujie, TIAN Suqing, WANG Cuiying, HE Donglei
2022, 49(1): 53-57. DOI: 10.3971/j.issn.1000-8578.2022.21.0794
Abstract FullText HTML PDF
Comparison of Intraoperative Ultrasound-guided Versus Technique Modified Subclavian Vein Puncture During Implantation of Totally Implanted Port
HU Xueli, PU Xiaolin, ZHANG Xianming
2022, 49(1): 58-61. DOI: 10.3971/j.issn.1000-8578.2022.21.0745
Abstract FullText HTML PDF
Advances in Molecular Targeting and Immunotherapy on Angiosarcomas
SUN Lu, SHI Hongwei, PI Guoliang
2022, 49(1): 62-66. DOI: 10.3971/j.issn.1000-8578.2022.21.1045
Abstract FullText HTML PDF
Influence of LncRNA NKILA on Biological Behavior of Malignant Tumors and Related Mechanism
ZHAO Yuqiao, LIU Guanglin, WANG Haicun, GAO Xin, JIANG Xingming, LIU Lang
2022, 49(1): 67-71. DOI: 10.3971/j.issn.1000-8578.2022.21.0792
Abstract FullText HTML PDF
Research Progress on Immunoregulation of Chemotherapeutic Agents
LIU Zhenghao, YANG Chunguang, HU Zhiquan
2022, 49(1): 72-77. DOI: 10.3971/j.issn.1000-8578.2022.21.0596
Abstract FullText HTML PDF
Anti-tumor Mechanism of Sonodynamic Combined with Hyperthermia and Its Application in Tumor
HAN Jiaxuan, ZHAO Yun
2022, 49(1): 78-82. DOI: 10.3971/j.issn.1000-8578.2022.21.1013
Abstract FullText HTML PDF

This work is licensed under a Creative Commons Attribution 3.0 License.

Email Alert RSS
Total visits： Visits today：